Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses

DOI: 10.2147/VHRM.S170141

Keywords: hypertension, eplerenone, aldosterone, cardiovascular, selective mineralocorticoid blocker

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text